https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 122, Issue 51, December 2025. <br/>SignificanceAdjuvant therapies can inhibit postsurgical tumor recurrence, while the applications of current therapeutic modalities are restricted by side effects after systemic infusion, repetitive dosing requirements, and limited efficacy. To address …
